From the FDA Drug Label
Minoxidil topical solution 5% is a clear, light amber liquid medication containing 5% minoxidil for use only on the scalp to help regrow hair in men. Minoxidil topical solution 5% is for use only by men Minoxidil topical solution 5% is for men with hair loss or thinning hair that begins on the vertex of the scalp. Clinically proven to help regrow hair. Reactivates hair follicles to stimulate regrowth.
Topical 5% Minoxidil (Rogaine) can help with androgenetic alopecia (hair loss) in men, particularly those with hair loss on the vertex of the scalp. It is clinically proven to help regrow hair and reactivates hair follicles to stimulate regrowth. Results may be seen as early as 2 months with twice daily use, but it may take at least 4 months for results to be seen 1.
From the Research
Topical 5% Minoxidil (Rogaine) is a recommended treatment for androgenetic alopecia (hair loss), as it has been shown to be effective in improving hair density and is FDA-approved. According to the most recent and highest quality study available, 2, topical minoxidil 2 to 5% is an effective standard medical treatment for androgenetic alopecia. The study highlights that minoxidil works by increasing blood flow to hair follicles, which can help to improve hair density and reduce hair loss.
Some key points to consider when using topical 5% Minoxidil (Rogaine) for hair loss include:
- It should be applied twice daily to the scalp
- It may take at least 6-12 months to see results
- It is essential to consult with a dermatologist before starting any hair loss treatment, especially combination products with multiple active ingredients that may increase the risk of side effects
- Other treatment options, such as oral finasteride 1mg daily (for men only), may also be effective, but it is crucial to discuss these options with a dermatologist to determine the best course of treatment.
It is also worth noting that while other treatments, such as low-level laser therapy (LLLT) and platelet-rich plasma (PRP), have been studied for their potential effectiveness in treating androgenetic alopecia, the evidence for these treatments is not as strong as it is for topical minoxidil and oral finasteride, as seen in studies such as 3 and 4. Therefore, topical 5% Minoxidil (Rogaine) remains a recommended treatment option for androgenetic alopecia due to its proven efficacy and FDA approval.